EICHOR
● Not Yet Recruiting
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2 · Sponsor: Eli Lilly and Company
About this study
This study looks at how well a medicine called orforglipron works compared to another medicine called dulaglutide in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how the body processes them. Participation in the study will last about 61 weeks.
This description comes directly from the study's public registry record.
Talk to the study team
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
Locations (71)
| Sutter Valley Medical Foundation (SVMF) Pediatric Endocrinology | Sacramento, California, United States | — |
| Rady Children's Hospital | San Diego, California, United States | — |
| Stamford Therapeutics Consortium | Stamford, Connecticut, United States | — |
| Children's Healthcare of Atlanta - Center for Advanced Pediatrics (CAP) | Atlanta, Georgia, United States | — |
| CenExel iResearch, LLC | Decatur, Georgia, United States | — |
| Medical Research Partners | Ammon, Idaho, United States | — |
| Cotton O'Neil Diabetes & Endocrinology | Topeka, Kansas, United States | — |
| SUNY Upstate Medical University | Syracuse, New York, United States | — |
| Advantage Clinical Trials | The Bronx, New York, United States | — |
| Central States Research | Tulsa, Oklahoma, United States | — |
| Frontier Clinical Research, LLC | Smithfield, Pennsylvania, United States | — |
| Vanderbilt Health One Hundred Oaks | Nashville, Tennessee, United States | — |
+ 59 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07668336